| | China's top pig producer Sichuan province pledged to produce 60 million hogs in 2020, around levels in previous years, state media reported on Friday, after a deadly pig disease decimated the country's massive pig herd. | |
| China has approved imports of Johnson & Johnson's Tremfya (guselkumab), the National Medical Products Administration said in a notice on Friday. | |
| (Reuters Health) - Almost 1 in 18 women and 1 in 40 men have experienced sexual harassment in and related to the workplace, according to a U.S. study. | |
| (Reuters Health) - Pregnant air travelers face a higher risk of blood clots, but they can reduce their risks by walking airplane aisles, drinking water and doing calf exercises, according to a new review. | |
| (Reuters Health) - Regular cannabis use has risen more quickly among people with depression, and they're less likely to perceive it as risky, compared with people who aren't depressed, a U.S. study suggests. | |
| (Reuters Health) - Screening fathers for postpartum depression is as important as screening mothers, researchers argue, and current guidelines don't go far enough in urging doctors to identify new fathers who may be suffering. | |
| (Reuters Health) - Transgender children may start to identify with toys and clothes typical of their gender identity from a very young age, a recent study suggests. | |
| (Reuters Health) - E-bikes and electric scooters are becoming increasingly popular in the United States, but the powered bikes carry a higher risk of severe injuries than traditional bicycles and a different pattern of injury risks compared with scooters, a recent study finds. | |
| (Reuters Health) - Diabetes medications and blood-test supplies are sold, traded and donated on black markets because the U.S. healthcare system isn't meeting patients' needs, a study shows. | |
| Many pot-smoking adults in Illinois will ring in the new year on a high note when recreational marijuana use becomes legal in the state on Jan. 1. | |
| Purchasers of Allergan Plc's Namenda asked a federal judge on Tuesday to approve a $750 million settlement of claims that the drugmaker conspired to keep generic versions of the Alzheimer's medication off the market. | |
|
| |